227 related articles for article (PubMed ID: 24168270)
1. Orthogonal assembly of a designed ankyrin repeat protein-cytotoxin conjugate with a clickable serum albumin module for half-life extension.
Simon M; Frey R; Zangemeister-Wittke U; Plückthun A
Bioconjug Chem; 2013 Nov; 24(11):1955-66. PubMed ID: 24168270
[TBL] [Abstract][Full Text] [Related]
2. Facile double-functionalization of designed ankyrin repeat proteins using click and thiol chemistries.
Simon M; Zangemeister-Wittke U; Plückthun A
Bioconjug Chem; 2012 Feb; 23(2):279-86. PubMed ID: 22188139
[TBL] [Abstract][Full Text] [Related]
3. Increasing the antitumor effect of an EpCAM-targeting fusion toxin by facile click PEGylation.
Simon M; Stefan N; Borsig L; Plückthun A; Zangemeister-Wittke U
Mol Cancer Ther; 2014 Feb; 13(2):375-85. PubMed ID: 24184633
[TBL] [Abstract][Full Text] [Related]
4. Novel prodrug-like fusion toxin with protease-sensitive bioorthogonal PEGylation for tumor targeting.
Stefan N; Zimmermann M; Simon M; Zangemeister-Wittke U; Plückthun A
Bioconjug Chem; 2014 Dec; 25(12):2144-56. PubMed ID: 25350699
[TBL] [Abstract][Full Text] [Related]
5. Half-life extension using serum albumin-binding DARPin® domains.
Steiner D; Merz FW; Sonderegger I; Gulotti-Georgieva M; Villemagne D; Phillips DJ; Forrer P; Stumpp MT; Zitt C; Binz HK
Protein Eng Des Sel; 2017 Sep; 30(9):583-591. PubMed ID: 29088432
[TBL] [Abstract][Full Text] [Related]
6. DARPins: a true alternative to antibodies.
Stumpp MT; Amstutz P
Curr Opin Drug Discov Devel; 2007 Mar; 10(2):153-9. PubMed ID: 17436550
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of albumin conjugates of a truncated peptide YY analogue for half-life extension.
Ehrlich GK; Michel H; Truitt T; Riboulet W; Pop-Damkov P; Goelzer P; Hainzl D; Qureshi F; Lueckel B; Danho W; Conde-Knape K; Konkar A
Bioconjug Chem; 2013 Dec; 24(12):2015-24. PubMed ID: 24251972
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery and endosomal cellular uptake of DARPin-siRNA bioconjugates: Influence of linker stability on gene silencing.
Lorenzer C; Streußnig S; Tot E; Winkler AM; Merten H; Brandl F; Sayers EJ; Watson P; Jones AT; Zangemeister-Wittke U; Plückthun A; Winkler J
Eur J Pharm Biopharm; 2019 Aug; 141():37-50. PubMed ID: 31103742
[TBL] [Abstract][Full Text] [Related]
9. Half-life extension of efficiently produced DARPin serum albumin fusions as a function of FcRn affinity and recycling.
Merten H; Brandl F; Zimmermann M; Schaefer JV; Irpinio L; Sand KMK; Nilsen J; Andersen JT; Zangemeister-Wittke U; Plückthun A
Eur J Pharm Biopharm; 2021 Oct; 167():104-113. PubMed ID: 34303832
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies of the serum half-life extension of a protein via site-specific conjugation to a species-matched or -mismatched albumin.
Yang B; Kim JC; Seong J; Tae G; Kwon I
Biomater Sci; 2018 Jul; 6(8):2092-2100. PubMed ID: 29881837
[TBL] [Abstract][Full Text] [Related]
11. Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size.
Zahnd C; Kawe M; Stumpp MT; de Pasquale C; Tamaskovic R; Nagy-Davidescu G; Dreier B; Schibli R; Binz HK; Waibel R; Plückthun A
Cancer Res; 2010 Feb; 70(4):1595-605. PubMed ID: 20124480
[TBL] [Abstract][Full Text] [Related]
12. Optimizing the anti-tumor efficacy of protein-drug conjugates by engineering the molecular size and half-life.
Brandl F; Busslinger S; Zangemeister-Wittke U; Plückthun A
J Control Release; 2020 Nov; 327():186-197. PubMed ID: 32768630
[TBL] [Abstract][Full Text] [Related]
13. Improved efficacy of alphavbeta3-targeted albumin conjugates by conjugation of a novel auristatin derivative.
Temming K; Meyer DL; Zabinski R; Senter PD; Poelstra K; Molema G; Kok RJ
Mol Pharm; 2007; 4(5):686-94. PubMed ID: 17683157
[TBL] [Abstract][Full Text] [Related]
14. Site-specific antibody-drug conjugation through glycoengineering.
Zhou Q; Stefano JE; Manning C; Kyazike J; Chen B; Gianolio DA; Park A; Busch M; Bird J; Zheng X; Simonds-Mannes H; Kim J; Gregory RC; Miller RJ; Brondyk WH; Dhal PK; Pan CQ
Bioconjug Chem; 2014 Mar; 25(3):510-20. PubMed ID: 24533768
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer.
Houvast RD; Badr N; March T; de Muynck LDAN; Sier VQ; Schomann T; Bhairosingh S; Baart VM; Peeters JAHM; van Westen GJP; Plückthun A; Burggraaf J; Kuppen PJK; Vahrmeijer AL; Sier CFM
Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2179-2192. PubMed ID: 37642704
[TBL] [Abstract][Full Text] [Related]
16. Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1.
Deyev SM; Vorobyeva A; Schulga A; Abouzayed A; Günther T; Garousi J; Konovalova E; Ding H; Gräslund T; Orlova A; Tolmachev V
Int J Biol Macromol; 2020 Feb; 145():216-225. PubMed ID: 31863835
[TBL] [Abstract][Full Text] [Related]
17. Antibody-Drug Conjugates for Tumor Targeting-Novel Conjugation Chemistries and the Promise of non-IgG Binding Proteins.
Merten H; Brandl F; Plückthun A; Zangemeister-Wittke U
Bioconjug Chem; 2015 Nov; 26(11):2176-85. PubMed ID: 26086208
[TBL] [Abstract][Full Text] [Related]
18. Identification of amino acid residues of a designed ankyrin repeat protein potentially involved in intermolecular interactions with CD4: analysis by molecular dynamics simulations.
Nimmanpipug P; Khampa C; Lee VS; Nangola S; Tayapiwatana C
J Mol Graph Model; 2011 Nov; 31():65-75. PubMed ID: 21962990
[TBL] [Abstract][Full Text] [Related]
19. Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity.
Doronina SO; Mendelsohn BA; Bovee TD; Cerveny CG; Alley SC; Meyer DL; Oflazoglu E; Toki BE; Sanderson RJ; Zabinski RF; Wahl AF; Senter PD
Bioconjug Chem; 2006; 17(1):114-24. PubMed ID: 16417259
[TBL] [Abstract][Full Text] [Related]
20. Stabilizing ionic interactions in a full-consensus ankyrin repeat protein.
Merz T; Wetzel SK; Firbank S; Plückthun A; Grütter MG; Mittl PR
J Mol Biol; 2008 Feb; 376(1):232-40. PubMed ID: 18155045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
